Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
8th grade Avg
|
New words:
absent, African, alan, allege, alleging, alliance, antikickback, Aselage, autoimmune, automatically, bad, Bienaim, bore, brand, branded, Bulletin, characterized, CIMA, civil, component, compulsory, concealing, constriction, convict, correctly, Correspondingly, criminal, curtail, defraud, depletion, deviation, dihydrochloride, dilation, drawn, dysfunction, EC, endothelial, endothelium, enhancing, environment, error, expenditure, false, falsifying, Fenner, forecasted, formulation, franchise, fraudulent, GMP, grey, headquartered, HHS, Iceland, impracticable, incorrect, indirectly, ineffective, inflammation, insignificant, Inspector, Italy, knowingly, layer, Lynch, marketplace, mechanical, mechanism, Medicare, Merrill, michael, MMA, molecule, Naglazyme, NaglazymeTM, NDA, negative, nitric, Nonqualified, Nonrefundable, Norway, notional, notwithstanding, Novasep, opt, outflow, overseeing, oxide, passage, pathologic, penalty, PhRMA, physiological, Pierce, PLC, Portability, postponed, principle, punishable, referral, relieve, remedy, remuneration, retrospective, SAB, safer, sapropterin, SAS, scheme, seizure, Serono, Shire, simplifying, Smith, solicit, South, Spain, speculative, statute, Stephen, suspend, suspended, suspension, Switzerland, synthetic, tied, underway, undesirable, unnecessary, unwanted, vascular, vessel, vibriolysin, violate, violating, violation, whichever
Removed:
abandon, abandonment, accrual, Aryplase, bear, biomedical, burden, burn, captured, Cdn, Chairman, Christopher, closure, community, consummated, contingency, distance, double, Electric, EMEA, enzymatic, equaled, exist, fall, fatigue, GBL, Grace, gwynn, height, leased, letter, List, noncash, obtainable, prepayment, privately, pronouncement, purport, realizing, relying, Repot, role, Synapse, traditional, transported, unaudited, unencumbered, Vancouver, weight
Filing tables
Filing exhibits
- 10-K Annual report
- 10.44 Services Agreement
- 21.1 List of Subsidiaries
- 23.1 Consent of KPMG LLP
- 23.2 Consent of Pricewaterhousecoopers, LLP
- 31.1 Certification of CEO Pursuant to Section 302
- 31.2 Certification of CFO Pursuant to Section 302
- 32.1 Certification of CEO Pursuant to Section 906
- 99.1 Biomarin/genzyme LLC, Financial Statements
Related press release
BMRN similar filings
Filing view
External links
Exhibit 23.2
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-3 (Nos. 333-116575, 333-108972, 333-102066) and Form S-8 (No. 333-85368, 333-84787) of BioMarin Pharmaceutical Inc. of our report dated March 6, 2006 relating to the financial statements of BioMarin/Genzyme LLC, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP
Boston, Massachusetts
March 6, 2006